Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]

View source ↗

Summary

An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• LY-4170156

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Status: RECRUITING